Phaos Technology Holdings (Cayman) (POAS) Total Current Liabilities (2024 - 2025)

Phaos Technology Holdings (Cayman) posted quarterly Total Current Liabilities of $3.6 million for Q4 2025, up 26.95% on a QoQ basis from $2.8 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Total Current Liabilities data on file, last reported at $3.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities changed N/A year-over-year to $3.6 million; the trailing twelve-month figure through Oct 2025 stood at $3.6 million (changed N/A YoY), and the FY2025 full-year result was $2.9 million, up 91.49% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $3.6 million, up from $2.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.6 million in Q4 2025 and bottomed at $1.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 18.38 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.50 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 4.57 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.41 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.22 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.53 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.15 Bn
10 Phaos Technology Holdings (Cayman) 6.83 Mn 6.73 Mn - 3.60 Mn

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 3.60 Mn
Apr 30, 2025 2.84 Mn
Apr 30, 2024 1.52 Mn